VEGFA and breast cancer: Vascular endothelial growth factors (VEGF) have been identified as major mediators of tumor angiogenesis, and aspirin decreased serum level of VEGF and suppressed the pro-angiogenic effects of tamoxifen in breast cancer patients, where interindividual variability was noted by the researchers (Holmes et al., 2008).